- Advertisement -

Neoplants Hopes to Curb Indoor Air Pollution with Bioengineered House Plants

A phrase commonly heard in gardens (and among gardeners) is “to plant a garden is to believe in tomorrow.” Although the originator, Audrey Hepburn,...

StockWatch: Investors Less Forgiving than Analysts as Verve Tumbles

Sekar Kathiresan, MD, Verve Therapeutics co-founder and CEO Investors punished Verve Therapeutics (VERV) this week—but analysts were far more forgiving—after it voluntarily paused an early-stage...

TeselaGen Biotechnology Teams Up with iGEM to Advance Synthetic Biology in Developing Countries – PR Web

iGEM 2019 TeselaGen is one of the most innovative start-ups in this space. By using TeselaGen's Design & Build modules, our...

Researchers identify DNA activation code using artificial intelligence

Reviewed by Emily Henderson, B.Sc.Sep 10 2020 Scientists have long known that human genes spring into action through instructions delivered by the precise order of...

How Subsecond Changes in Brain Dopamine Levels Impact Human Behavior

What happens in the human brain when we learn from positive and negative experiences? To help answer that question and better understand decision making...

Lincoln Laboratory establishes Biotechnology and Human Systems Division – MIT News

MIT Lincoln Laboratory has established a new research and development division, the Biotechnology and Human Systems Division. The division will address emerging threats to...

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key tumor defense against...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...

more new items

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...